Eric Vaught is an accomplished medical executive skilled in leading business, financial, and operations strategy, with focused expertise gained in key leadership roles within Healthcare industry. He is skilled in team leadership, growth strategies, and relationship management. Eric has a proven record of achieving high-quality outcomes through development of strategies that increase productivity and efficiency. He is a results-driven, strategic leader actively seeking opportunities to transform healthcare that is patient centered, fulfilling for the healthcare team, and economically sustainable.

Eric is a strong, decisive, hands-on leader – analytical, innovative, dedicated, quick-thinking and tenacious. He possesses exceptional problem solving and decision making skills. His career in regulatory affairs and quality managements spans military and private world-class health care facilities and integrates multi-national compliance organizations, as well as integrates the entrepreneurial ventures in the pharmaceuticals and medical philanthropic industries. There is considerable evidence of his consistent success in the rapid growth of his current organization in the process improvements, market share growth and organizational excellence.

Eric was previously the Chief Medical Officer at Healthfirst Family Care Center in Fall River, MA where he managed 22 clinicians and 90 support staff to serve 14,000 primary care and behavioral health patients. His team has handled over 50,000 patient visits annually and arranged numerous outreach events by working with community partners to improve the overall health of the Fall River community.  Eric oversees a $22 million annual budget, representing a 37% increase from 2020. He has consistently delivered exceptional patient care experiences through patient care management, collaborative leadership, patient engagement, and systems optimization.

Eric served as a senior member of the US Naval European medical team with primary accountabilities for the multi-national management of the regulatory and clinical operations organizations and its operating systems/processes and creating regulatory/clinical strategies for new and evolving disease management protocols, devices and pharmaceutical integrations during COVID pandemic response. The team consisted of 72 professionals with a budget of $25M. As lead of clinical operations, Eric oversaw 8 geographically isolated sites on three continents which all met or exceeded international and US government regulations as well as business development objectives, timelines and budgets. Eric championed risk mitigation efforts by monitoring adverse events, ensuring clinical quality assurance protocols and allotted resources were in regulatory compliance, and ultimately reduce cost and minimize exposure risks.